For Healthcare Professionals
Lost to Follow-Up (LTFU) Patients and Their Journey to Treatment
A PKU expert provides insights into the number of adult patients who have become lost to follow-up while a patient shares his journey back to treatment with PALYNZIQ.
Indication
PALYNZIQ is a phenylalanine (Phe)-metabolizing enzyme indicated to reduce blood Phe concentrations in adult patients with phenylketonuria who have uncontrolled blood Phe concentrations greater than 600 micromol/L on existing management.
Please see full Prescribing Information, with Boxed Warning for risk of anaphylaxis, and Medication Guide, here.

For Healthcare Professionals
Listen to PKU experts review PALYNZIQ’s safety and efficacy, and discuss the clinical considerations that their team evaluates when administering PALYNZIQ.

For Healthcare Professionals
Listen to one clinic’s considerations during the initial screening of adult patients with PKU for starting PALYNZIQ treatment.

For Healthcare Professionals
Hear how a Nurse Practitioner and Registered Dietitian provide ongoing care to adult PKU patients during their treatment with PALYNZIQ.

For Healthcare Professionals
Deep dive into PALYNZIQ's safety profile with the help of PKU experts.

For Healthcare Professionals
PKU experts discuss PALYNZIQ’s mechanism of action and long-term efficacy data.

For Healthcare Professionals
PKU experts share PALYNZIQ’s dosing and administration, including dose options up to 60 mg once daily.

For Healthcare Professionals
Watch a discussion of unique adult PKU patient case studies, including considerations taken to manage these patients using PALYNZIQ.

For Patients
This educational video helps patients learn about the potential for a severe allergic reaction with PALYNZIQ.

For Patients
This video helps address patient fears about needles and injections by reviewing specific product information, and the support they’ll receive with PALYNZIQ.

For Patients
Get to know Sarah and learn about her experience starting PALYNZIQ.

For Patients
Patients can learn how the immune system responds to PALYNZIQ.

For Healthcare Professionals
PKU experts review the safety and efficacy data on PALYNZIQ, then discuss some of the unique clinical considerations when treating young adult patients with PKU. Hear from two experts who discuss their management approaches through real-world patient cases detailing young adults taking PALYNZIQ while transitioning to independence.